These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37173614)

  • 1. Implications of uremic cardiomyopathy for the practicing clinician: an educational review.
    Hiraiwa H; Kasugai D; Okumura T; Murohara T
    Heart Fail Rev; 2023 Sep; 28(5):1129-1139. PubMed ID: 37173614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.
    Wang X; Liu J; Drummond CA; Shapiro JI
    Expert Opin Ther Targets; 2017 May; 21(5):531-541. PubMed ID: 28338377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvolt T-wave alternans in end-stage renal disease patients--associations with uremic cardiomyopathy.
    Patel RK; Mark PB; Halliday C; Steedman T; Dargie HJ; Cobbe SM; Jardine AG
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):519-27. PubMed ID: 21088291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic abnormalities and uremic cardiomyopathy.
    Stewart GA; Gansevoort RT; Mark PB; Rooney E; McDonagh TA; Dargie HJ; Stuart R; Rodger C; Jardine AG
    Kidney Int; 2005 Jan; 67(1):217-26. PubMed ID: 15610245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of renal transplantation on uremic cardiomyopathy.
    Parfrey PS; Harnett JD; Foley RN; Kent GM; Murray DC; Barre PE; Guttmann RD
    Transplantation; 1995 Nov; 60(9):908-14. PubMed ID: 7491692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremic cardiomyopathy: an underdiagnosed disease.
    Alhaj E; Alhaj N; Rahman I; Niazi TO; Berkowitz R; Klapholz M
    Congest Heart Fail; 2013; 19(4):E40-5. PubMed ID: 23615021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic cardiomyopathy and insulin resistance: a critical role for akt?
    Semple D; Smith K; Bhandari S; Seymour AM
    J Am Soc Nephrol; 2011 Feb; 22(2):207-15. PubMed ID: 20634295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy.
    Nguyen TD; Schulze PC
    Circ Res; 2023 Apr; 132(8):1034-1049. PubMed ID: 37053280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripartum cardiomyopathy.
    Murali S; Baldisseri MR
    Crit Care Med; 2005 Oct; 33(10 Suppl):S340-6. PubMed ID: 16215357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of Soluble α-Klotho as an Independent Cause of Uremic Cardiomyopathy.
    Xie J; Wu YL; Huang CL
    Vitam Horm; 2016; 101():311-30. PubMed ID: 27125747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is uremic cardiomyopathy a direct consequence of chronic kidney disease?
    Chinnappa S; Hothi SS; Tan LB
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):127-30. PubMed ID: 24404903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe left ventricular systolic dysfunction may reverse with renal transplantation: uremic cardiomyopathy and cardiorenal syndrome.
    Zolty R; Hynes PJ; Vittorio TJ
    Am J Transplant; 2008 Nov; 8(11):2219-24. PubMed ID: 18808406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease.
    Wollenhaupt J; Frisch J; Harlacher E; Wong DWL; Jin H; Schulte C; Vondenhoff S; Moellmann J; Klinkhammer BM; Zhang L; Baleanu-Curaj A; Liehn EA; Speer T; Kazakov A; Werner C; van der Vorst EPC; Selejan SR; Hohl M; Böhm M; Kramann R; Biessen EAL; Lehrke M; Marx N; Jankowski J; Maack C; Boor P; Prates Roma L; Noels H
    Redox Biol; 2022 Oct; 56():102459. PubMed ID: 36099852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.
    Grabner A; Faul C
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):314-24. PubMed ID: 27219043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcimimetic combined with an angiotensin-converting enzyme inhibitor on uremic cardiomyopathy progression.
    Mizobuchi M; Ogata H; Hosaka N; Kumata C; Nakazawa A; Kondo F; Koiwa F; Kinugasa E; Akizawa T
    Am J Nephrol; 2011; 34(3):256-67. PubMed ID: 21791922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic evaluation of left ventricular dimensions and function in chronic hemodialysis patients with cardiomegaly.
    Renger A; Müller M; Jutzler GA; Bette L
    Clin Nephrol; 1984 Mar; 21(3):164-8. PubMed ID: 6231149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy.
    London GM; Fabiani F; Marchais SJ; de Vernejoul MC; Guerin AP; Safar ME; Metivier F; Llach F
    Kidney Int; 1987 Apr; 31(4):973-80. PubMed ID: 2953925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.
    Kovács ZZA; Szűcs G; Freiwan M; Kovács MG; Márványkövi FM; Dinh H; Siska A; Farkas K; Kovács F; Kriston A; Horváth P; Kővári B; Cserni BG; Cserni G; Földesi I; Csont T; Sárközy M
    Sci Rep; 2021 Sep; 11(1):17495. PubMed ID: 34471171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac manifestations of terminal kidney insufficiency. Current characterization of uremic cardiomyopathy].
    Josephs W; Odenthal HJ
    Dtsch Med Wochenschr; 1995 Feb; 120(5):141-4. PubMed ID: 7843032
    [No Abstract]   [Full Text] [Related]  

  • 20. Uremic cardiomyopathy: role of circulating digitalis like substances.
    Mohmand B; Malhotra DK; Shapiro JI
    Front Biosci; 2005 Sep; 10():2036-44. PubMed ID: 15970476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.